Pricing Log in Create free account

Drugs Made In America Acquisition Corp. (DMAA) vs Muzero Acquisition Corp (MUZE)

Drugs Made In America Acquisition Corp. and Muzero Acquisition Corp are both Shell Companies companies. Drugs Made In America Acquisition Corp. and Muzero Acquisition Corp are of similar size ($273.3M and $264.4M).

Valuation

Metric DMAA MUZE Shell Companies median
P/E — — 30.90
P/S — — —
P/B — — 84.01
Price to free cash flow — — —
EV/EBITDA — — —
EV/Sales — — —
Earnings yield — — 2.82%
Free cash flow yield — — 0.00%

Profitability

Metric DMAA MUZE Shell Companies median
Gross margin — — —
Operating margin — — 0.00%
Net margin — — 0.00%
Free cash flow margin — — 0.00%
Return on equity — — (0.35%)
Return on assets — — 2.50%
Return on invested capital — — 0.00%

Growth

Metric DMAA MUZE Shell Companies median
Revenue growth (TTM) — — —
EPS growth (last fiscal year) — — 81.42%
Revenue growth, 5-year CAGR — — —
Net income growth, 5-year CAGR — — —

Health

Metric DMAA MUZE Shell Companies median
Debt to equity — — 0.00
Current ratio — — 1.41
Net debt to EBITDA — — 0.33

Dividend

Metric DMAA MUZE Shell Companies median
Dividend yield — — —
Payout ratio — — —

Size

Metric DMAA MUZE Shell Companies median
Market cap 264.37m 273.34m 238.75m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack